trimethylenediamine has been researched along with Peritoneal Carcinomatosis in 1 studies
trimethylenediamine: RN given refers to parent cpd; structure
trimethylenediamine : An alkane-alpha,omega-diamine comprising a propane skeleton with amino substituents at positions 1 and 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of combined administration of bombesin (40 micrograms/kg body weight) and the ornithine decarboxylase (ODC) inhibitor, 1,3-diaminopropane (DAP), on the development of large and small intestinal tumors and the incidence of their metastasis to the peritoneum induced by azoxymethane (AOM, 7." | 3.69 | Ornithine decarboxylase inhibitor attenuates bombesin enhancement of intestinal carcinogenesis and metastasis induced by azoxymethane. ( Baba, M; Iishi, H; Nakaizumi, A; Tatsuta, M; Uehara, H, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iishi, H | 1 |
| Tatsuta, M | 1 |
| Baba, M | 1 |
| Uehara, H | 1 |
| Nakaizumi, A | 1 |
1 other study available for trimethylenediamine and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Ornithine decarboxylase inhibitor attenuates bombesin enhancement of intestinal carcinogenesis and metastasis induced by azoxymethane.
Topics: Adenocarcinoma; Animals; Azoxymethane; Body Weight; Bombesin; Cell Division; Diamines; Drug Synergis | 1994 |